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Abstract
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and
Allergies (NDA) was asked to deliver a scientiﬁc opinion related to a notiﬁcation from DuPont Nutrition
Biosciences Aps on behenic acid from mustard seeds to be used in the manufacturing of certain
emulsiﬁers pursuant to Article 21(2) of Regulation (EU) No 1169/2011 – for permanent exemption
from labelling. Behenic acid is produced from rapeseed–mustard seed variants prevalent in India,
namely Brassica juncea (L.) Czern. (oriental mustard), Brassica rapa (L.) (brown/yellow Sarson or
Toria), Brassica napus (L.) (rapeseed) and Brassica nigra (L.) W.D.J.Koch (black mustard). No human
or animal allergenicity data were provided by the applicant for either behenic acid or the emulsiﬁers
manufactured from behenic acid. Based on enzyme-linked immunosorbent assay (ELISA) data, the
Panel considers that proteins and peptides may not be carried over into behenic acid after the two
distillation steps reported in the manufacturing process in amounts beyond 1 mg/kg. The Panel notes
that the maximum amount of mustard protein that could be consumed from emulsiﬁers manufactured
from behenic acid (E 470a, E 471 and E 477) on a single occasion by an adult under the proposed
conditions of use would be around 0.00119 mg, which is about 1,000 times lower than the protein
doses reported to trigger allergic reactions in mustard-allergic individuals (around 1 mg). On the basis
of the data presented, the Panel concludes that oral consumption of emulsiﬁers manufactured using
behenic acid from mustard seeds (E 470a, E 471 and E 477) are unlikely to trigger an allergic reaction
in susceptible individuals (i.e. mustard-allergic individuals) under the proposed conditions of use.
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Summary
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and
Allergies (NDA) was asked to deliver a scientiﬁc opinion related to a notiﬁcation from DuPont Nutrition
Biosciences Aps on behenic acid from mustard seeds to be used in the manufacturing of certain
emulsiﬁers pursuant to Article 21(2) of Regulation (EU) No 1169/2011 – for permanent exemption
from labelling.
Taking into account the well-documented reports of allergic individuals reacting to mustard, it is
appropriate for the Panel to assess the likelihood of adverse reactions in allergic individuals consuming
products derived from mustard.
The food allergen-derived preparation for which the exemption from labelling is requested is behenic
acid. The food allergen-derived foodstuffs are emulsiﬁers (i.e. E 470a, E 471, E 472 (a, b, c and e),
E 475 and E 477), which could be manufactured from behenic acid and be used as food additives.
Behenic acid is produced from rapeseed–mustard seed variants prevalent in India, namely
Brassica juncea (L.) Czern. (oriental mustard), Brassica rapa (L.) (brown/yellow Sarson or Toria),
Brassica napus (L.) (rapeseed) and Brassica nigra (L.) W.D.J.Koch (black mustard).
Sin a 1, Sin a 2, Sin a 3 and Sin a 4 are mustard allergens present in Sinapis alba (yellow mustard),
which is not used for the production of behenic acid, whereas the relevant mustard allergen in
B. juncea (oriental mustard) is Bra j 1. The major allergen of rapeseed (B. napus) is Bra n 1. The
Panel notes that homologous proteins of Sin a 1 and Bra n 1 are also potentially allergenic for
mustard-sensitive individuals.
A detailed description of the manufacturing process of behenic acid and the emulsiﬁers thereof was
provided by the applicant. Following a request by the European Food Safety Authority (EFSA), no data
were provided on the residual total protein content of behenic acid. Instead, the applicant argued that
proteins and peptides are unlikely to be carried over into the distillate following the two sequential
distillation steps described in the manufacturing process of behenic acid. The Panel considers that the
presence of mustard proteins in behenic acid cannot be excluded on the basis of the manufacturing
process only.
The Panel notes that the maximum use level estimated by the applicant for adults for the combined
intake of E 470a, E 471 and E 477 (1,400 mg/day, assumed to be on a single occasion in a
conservative approach) is similar to that reported in the literature for E 475 (1,174 mg), and can be
considered the highest estimate for all population groups. The Panel also notes that E 472a–e and
E 475, which are currently not manufactured with behenic acid, have not been considered by the
applicant in the intake estimate.
No human or animal allergenicity data were provided by the applicant for either behenic acid or the
emulsiﬁers manufactured from behenic acid.
Three different batches of behenic acid were tested using an enzyme-linked immunosorbent assay
(ELISA) test for mustard seed proteins with a limit of quantiﬁcation (LOQ) of 1 mg/kg. The assay was
developed using seed proteins from S. alba and B. nigra. The assay has been shown to detect seed
proteins from S. alba and B. nigra, but also from B. juncea, using positive standards with known
amounts of seed proteins from these three species of mustard. The Panel considers that the assay was
appropriate for testing the presence of residual mustard allergens in samples of behenic acid. Mustard
allergens were not detected in any of the batches. The results of a passive sensitisation histamine
release test (HR-test) applied to six batches of behenic acid provided only limited evidence that
residual mustard in behenic acid may be < 0.03 mg/kg.
Considering that the highest amount of emulsiﬁers ingested per person on a single occasion is
1,400 mg for adults, that behenic acid constitutes 25–85% of the ﬁnal emulsiﬁer, and that the typical
amount of an emulsiﬁer in a food item is maximum 1% on a weight basis, the applicant calculated
the maximum amount of mustard protein that could be consumed from emulsiﬁers manufactured from
behenic acid on a single occasion by an adult using the limit of detection (LOD) of 0.03 mg/kg
from the passive sensitisation HR-test. However, the Panel considers that using the LOQ of 1 mg/kg
from the ELISA assay would be more appropriate, as follows:
ð1,400mg 85 1mg/kgÞ : ð100 1,000,000Þ ¼ 0:00119mg mustard proteins:
The Panel considers that mustard allergens may not be carried over into behenic acid after the two
distillation steps reported in the manufacturing process in amounts beyond 1 mg/kg. No human or
animal data on the allergenicity of either behenic acid or the emulsiﬁers manufactured thereof in vivo
were provided by the applicant. The Panel notes, however, that the maximum amount of mustard
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protein that could be consumed from emulsiﬁers manufactured from behenic acid (E 470a, E 471 and
E 477) on a single occasion by an adult under the proposed conditions of use would be around
0.00119 mg, which is about 1,000 times lower than the protein doses reported to trigger allergic
reactions in mustard-allergic individuals (around 1 mg).
On the basis of the data presented, the Panel concludes that oral consumption of emulsiﬁers
(E 470a, E 471 and E 477) manufactured using behenic acid from mustard seeds is unlikely to trigger
an allergic reaction in susceptible individuals (i.e. mustard-allergic individuals) under the proposed
conditions of use.
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1. Introduction
1.1. Background and Terms of Reference as provided by the requestor
1.1.1. Background
Annex II to Regulation (EU) No 1169/2011 (hereafter ‘the Regulation’) includes an European Union
(EU) list of food substances or products known as likely to trigger adverse reactions in sensitive
individuals, and therefore their presence in foods must be indicated. This list has been established on
the basis of the scientiﬁc opinions of the European Food Safety Authority (EFSA).1 According to the
latter, those substances are considered as part of the most common food allergens and there is
sufﬁcient evidence to support their inclusion into the list.
In order to ensure better information to consumers and to take account of the most recent
scientiﬁc progress and technical knowledge, Article 21 paragraph 2 of the Regulation requires the
Commission to systemically re-examine, and where necessary, update the list in Annex II, in
accordance with Article 51 of the Regulation.
Pursuant to Article 5 of the same legislation, any Union measure in the ﬁeld of food information law
which is likely to have an effect on public health shall be adopted after consultation of EFSA on the
basis of Article 29 of Regulation (EC) No 178/20022. The update of the list may also consist in the
deletion of food allergens for which it has been scientiﬁcally established that it is impossible to cause
adverse reactions. To this end, the interested parties may communicate to the Commission studies
establishing that certain products derived from substances listed in Annex II are unlikely to trigger
adverse reactions in individuals.
The EFSA’s Panel on Dietetic Products, Nutrition and Allergies (NDA) had delivered a scientiﬁc
opinion on scientiﬁc and technical guidance for the preparation and presentation of such applications.
It is conﬁrmed that this request is in line with this guidance.3
1.1.2. Terms of Reference
In accordance with Article 29 (1) (a) of Regulation (EC) No 178/2002, the European Commission
requests the EFSA to evaluate the scientiﬁc data submitted by the DuPont Nutrition Biosciences Aps in
the context of the re-examination of the Annex II to Regulation (EU) No 1169/2011 as requested in
Article 21(2) of the latter.
EFSA is requested to issue an opinion on the information provided, and particularly to consider the
likelihood of adverse reactions triggered in susceptible individuals by the consumption of the following
ingredients/substances used under the conditions speciﬁed by the applicant: behenic acid used in the
manufacturing of emulsiﬁers, namely,
E 470a: sodium, potassium and calcium salts of fatty acids
E 471: mono- and diglycerides of fatty acids
E 477: propane-1,2-diol esters of fatty acids
The following emulsiﬁers are currently not manufactured with behenic acid, and are therefore not
included in the calculation of intake. However, new applications requiring the technological properties
of an emulsiﬁer made with behenic acid may evolve.
E 472a: acetic acid esters of mono- and diglycerides of fatty acids
E 472b: lactic acid esters of mono- and diglycerides of fatty acids
E 472c: citric acid esters of mono- and diglycerides of fatty acids
E 472e: mono- and diacetyl tartaric acid esters of mono- and diglycerides of fatty acids
E 475: polyglycerol esters of fatty acids
1 http://www.efsa.europa.eu/EFSA/Scientiﬁc_Opinion/opinion_nda_04_en1,1.pdf
2 Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general
principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in
matters of food safety, OJ L 31, 1.2.2002.
3 http://www.efsa.europa.eu/en/efsajournal/doc/3417.pdf
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2. Data and methodologies
2.1. Data
Notiﬁcation from DuPont Nutrition Biosciences Aps on behenic acid to be used in the manufacturing
of emulsiﬁers pursuant to Article 21(2) of Regulation (EU) No 1169/2011 for permanent exemption from
labelling, presented in a common and structured format as outlined in the Guidance on the preparation
and presentation of applications pursuant to Article 6 Paragraph 11 of Directive 2000/13/EC, as
amended.4 As outlined in that guidance document, it is the duty of the applicant to provide all pertinent
scientiﬁc data in the application (published and unpublished, data in favour and not in favour) relative
to the assessment of the likelihood of adverse reactions being triggered in sensitive individuals by
the oral consumption of the food allergen-derived preparation/foodstuff(s) under the proposed
conditions of use.
2.2. Methodologies
The general approach of the NDA Panel for the evaluation of applications on food ingredients or
substances with known allergenic potential is outlined in the Guidance on the preparation and
presentation of applications pursuant to Article 6 Paragraph 11 of Directive 2000/13/EC, as amended.4
3. Assessment
3.1. Introduction
The mustard plant belongs to the Brassicaceae (formerly Cruciferae) family. White/yellow
(Sinapis alba (L.), black (Brassica nigra (L.) W.D.J.Koch) and brown/oriental mustard (Brassica juncea
(L.) Czern.) are the main types of mustard seeds used in cuisine and food processing. Mustard powder
commercially available is usually a mixture of ground white and black mustard seeds. White and brown
seeds are blended to make the English style mustard. White mustard seeds are the main ingredient in
North American mustard, while the brown seeds are mainly used in Europe and China. Black mustard
is mostly used in Indian cuisine. Mustard oil is also widely used as an edible oil and as a ﬂavouring
agent in India (EFSA NDA Panel, 2014).
Data on the prevalence of mustard sensitisation, clinical mustard allergy and the incidence of
severe allergic reactions to mustard in the general population are lacking. However, the potential
severity of mustard allergy has been described by several authors. Anaphylactic reactions have been
reported in 2% of children and in up to 48% of adults with conﬁrmed mustard allergy (EFSA NDA
Panel, 2014).
Taking into account the well-documented reports of allergic individuals reacting to mustard, it is
appropriate for the Panel to assess the likelihood of adverse reactions in allergic individuals consuming
products derived from mustard.
The present opinion is based on a dossier submitted by DuPont Nutrition Biosciences Aps for
permanent exemption from labelling of behenic acid to be used in the manufacturing of emulsiﬁers,
pursuant to Article 21(2) of Regulation (EU) No 1169/2011. Behenic acid (docosanoic acid C22H44O2,
C22:0) is obtained from a fraction of fully hydrogenated reﬁned mustard seed oil and can be used for
the synthesis of several emulsiﬁers (i.e. E 470a, E 471, E 472 (a, b, c and e), E 475 and E 477).
Emulsiﬁers are food additives permitted for use in a number of food categories.
3.2. Food allergen-derived preparation
The food allergen-derived preparation for which the exemption from labelling is requested is
behenic acid. Behenic acid is a fraction of fully hydrogenated reﬁned mustard seed oil (a product of
mustard).
The majority of behenic acid used for the manufacture of food emulsiﬁers is imported from India. It
is obtained from reﬁned, bleached and deodorised oil of rapeseed or mustard origin, which can include
oil from the mustard strains B. juncea (L.) Czern. (oriental mustard) and B. nigra (L.) W.D.J.Koch
4 EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2013. Guidance on the preparation and
presentation of applications pursuant to Article 6 Paragraph 11 of Directive 2000/13/EC, as amended. EFSA Journal 2013; 11(10):
3417, 17 pp. doi:10.2903/j.efsa.2013.3417
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(black mustard), but also from the rapeseed strains Brassica rapa (L.) (brown/yellow Sarson or Toria)
and Brassica napus (L.) (rapeseed). The Panel notes that both mustard and rapeseed share the
presence of allergens belonging to the 2S albumin family, which is a complex protein fraction
characterised by multiple isoforms.
3.3. Conditions of use
The applicant speciﬁes that behenic acid will not be consumed as such, but rather used in the
manufacturing of the following emulsiﬁers:
E 470a: sodium, potassium and calcium salts of fatty acids
E 471: mono- and diglycerides of fatty acids
E 477: propane-1,2-diol esters of fatty acids.
The applicant also speciﬁes that other emulsiﬁers could be manufactured in the future by using
behenic acid, such as:
E 472a: mono- and diglycerides of fatty acids esteriﬁed with acetic acid
E 472b: mono- and diglycerides of fatty acids esteriﬁed with lactic acid
E 472c: mono- and diglycerides of fatty acids esteriﬁed with citric acid
E 472e: mono- and diglycerides of fatty acids esteriﬁed with mono- and diacetyltartaric acid
E 475: polyglycerol esters of fatty acids.
3.4. Anticipated intake/exposure
The emulsiﬁers made with behenic acid are permitted for use in a number of food categories.
According to the applicant, the ﬁnal content of behenic acid in the emulsiﬁer is 25–85%, depending on
the type of emulsiﬁer manufactured, and the typical amount of an emulsiﬁer in a food item is 1%
maximum on a weight basis.
The applicant claims that, although E 470a, E 471 and E 477 can be used in a variety of foods,
there are only few applications where the functional properties of emulsiﬁers manufactured with
behenic acid are needed.
E 470a and E 471 belong to the group I additives according to Regulation (EC) No 1129/20115 and
may be used in a wide range of food categories at quantum satis level. E 470a is predominantly used
in edible ice creams with a typical use level of 500 mg/kg. E 471 is mostly used in fat and oil
emulsions including spreads and liquid emulsions at typical use levels of 5,000 mg/kg, and in
decorations, coatings and ﬁllings, except fruit based ﬁllings, at typical use levels of 7,500 mg/kg.
E 477 is used according to maximum and typical use levels depicted in Table 1.
A rough estimate of the daily combined dietary exposure to E 470a, E 471 and E 477 has been
calculated by the applicant using the Food Additive Intakes Model. This approach is based on the
assumption that an individual is a high consumer of one food category only and an average consumer
of all the remaining food categories. The method consists of adding the highest level of exposure from
one food category (calculated for consumers only) to the mean exposure values for the remaining
categories (calculated for the total population) (EFSA, 2015). The results for different age groups
according to use level are depicted in Table 2.
Table 1: Maximum and typical use levels of E 477
Food category Maximum use levels Typical use level
Fat and oil emulsions including
spreads and liquid emulsions
Only fat emulsions for baking purposes:
10,000 mg/kg
5,000 mg/kg
Fine bakery wares 5,000 mg/kg 2,500 mg/kg
5 Commission Regulation (EU) No 1129/2011 of 11 November 2011 amending Annex II to Regulation (EC) No 1333/2008 of the
European Parliament and of the Council by establishing a Union list of food additives. OJ L 295, pp. 1–177.
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The estimated combined intake of E 470a, E 471 and E 477 at the maximum permitted levels could
lead to a maximum total exposure of 84 mg/kg body weight (bw) per day for toddlers and 20 mg/kg
bw per day for adults. Using a reference body weight of 12 kg for toddlers and of 70 kg for adults, the
highest amount of emulsiﬁers ingested per person per day would be 1,008 mg for toddlers and
1,400 mg for adults. As a conservative approach, it could be assumed that these doses could be
consumed on a single occasion. The Panel notes that the intake for these population subgroups with
the maximum use levels is much lower, i.e. 25.5 mg/kg bw per day for toddlers and 9.6 mg/kg bw per
day for adults, respectively (Table 2).
It has been reported (Vin et al., 2013) that the highest tier 3 estimates of daily dietary intake of
E 475 in France, Ireland, Italy and the United Kingdom showed a 97.5th percentile intake of 97.8 mg/kg
bw per day in children and of 9.5 mg/kg bw per day in adults, while the median exposure was
estimated to be 7.1 and 3.3 mg/kg bw per day, respectively. Using a reference body weight of 12 kg for
toddlers and of 70 kg for adults, the highest amount ingested per person per day for the 97.5th
percentile would be 1,174 mg for children and 665 mg for adults.
The Panel notes that the maximum use level estimated for adults by the applicant for the combined
intake of E 470a, E 471 and E 477 of 1,400 mg is similar to that reported in the literature for E 475,
and can be considered the highest estimate for all population groups. The Panel also notes that
E 472a–e and E 475, which are currently not manufactured with behenic acid, have not been
considered by the applicant in the intake estimate.
3.5. Characteristics of the food allergen-derived preparation/foodstuff(s)
3.5.1. Food allergen-derived preparation (behenic acid)
3.5.1.1. General speciﬁcations
Behenic acid is produced from rapeseed–mustard seed variants prevalent in India, namely
B. juncea (L.) Czern. (oriental mustard), B. rapa (L.) (brown/yellow Sarson or Toria), B. napus (L.)
(rapeseed) and B. nigra (L.) W.D.J.Koch (black mustard).
Behenic acid (docosanoic acid; C22H44O2, C22:0) (CAS No: 112-85-6) is produced as a light
solid with a minimum 85% purity and insoluble in water. The chemical and physical data are reported
in Table 3.
Table 2: Combined intake of E 470a, E 471 and E 477 for different age groups according to use
level
Total estimated exposure (mg/kg bw per day)
Maximum permitted levels Use levels
Range for mean
across dietary
surveys
Range for
highest level
across dietary
surveys
Range for mean
across dietary
surveys
Range for high
level across
dietary surveys
Min Max Min Max Min Max Min Max
Toddlers (1 to < 3 years) 2.56 29.53 8.42 84.12 2.01 11.28 7.86 25.49
Children (3 to < 10 years) 6.85 24.67 11.56 63.01 4.32 11.42 10.46 25.87
Adolescents (10 to <18 years) 3.53 12.58 6.76 29.02 1.84 6.98 6.10 15.17
Adults (18 to < 65 years) 1.82 7.16 4.99 20.49 1.36 3.57 4.59 9.65
Elderly (65 to < 75 years) 2.02 7.14 4.76 23.04 1.10 4.56 3.66 9.64
bw: body weight.
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The product, analysed by gas chromatography, is also shown to contain other fatty acid lower
homologues (≤ C18, max 5%), such as stearic acid (octadecanoic acid; C18H36O2), and arachidic acid
(eicosanoic acid, C20H40O2 max 12%), as well as higher homologues (> C22, max 4%).
3.5.1.2. Manufacturing process
Rapeseed–mustard seeds are crushed in an expeller at the oil mill and the crude oil obtained is
reﬁned, bleached and deodorised at the reﬁnery. The fully reﬁned oil is hydrolysed under high pressure
steam at high temperature to obtain the free fatty acids. The monounsaturated erucic acid ((Z)–docos-
13-enoic acid; C22H42O2, C22:1) is separated by fractional distillation under vacuum and hydrogenated
using a nickel catalyst under high pressure and heating conditions to produce behenic acid, which is
then puriﬁed by distillation under vacuum.
The manufacturing process conforms to the British Retail Consortium (BRC) Global Standard of
Food Safety (Issue 6, July 2011) and the ISO 9001:2008 Management Standards.
The Panel notes that, following a request by EFSA, no data were provided on the residual total
protein content of behenic acid. Instead, the applicant argued that proteins and peptides are unlikely
to be carried over into the distillate following the two sequential distillation steps described in the
manufacturing process of behenic acid. The Panel considers that the presence of mustard proteins in
behenic acid cannot be excluded on the basis of the manufacturing process only.
3.5.1.3. Allergen speciﬁcations
The applicant states that, since behenic acid is made in part from mustard seeds, relevant allergens
are the mustard allergens Sin a 1, Sin a 2, Sin a 3, Sin a 4 and Bra j 1. The Panel notes that Sin a 1,
Sin a 2, Sin a 3 and Sin a 4 are mustard allergens present in S. alba (yellow mustard), which is not
used for the production of behenic acid, whereas the relevant mustard allergen in B. juncea (oriental
mustard) is Bra j 1. However, Bra j 1 is a 2S seed storage albumin similar to Sin a 1 in structure and
amino acid composition (Gonzalez de la Pe~na et al., 1991), with an identity of 86% and a sequence
similarity of 91%. Bra j 1 and Sin a 1 have also been reported to share a homologous epitope, so that
antibodies reacting to one type of mustard may also react to other types (Monsalve et al., 1993).
The major allergen of rapeseed (B. napus), Bra n 1 (Monsalve et al., 1997), is a close homologue of
Sin a 1, with 92% identity and 94% sequence similarity. The antigenic properties of Bra n 1 were studied
in comparison with Sin a 1 by using sera from individuals sensitised to mustard and rapeseed proteins,
showing that these two proteins share common antigenic and allergenic determinants. Cross-reactivity
between the proteins of rape and mustard seeds has been reported (Meding, 1985; Widstrom and
Johansson, 1986; Monreal et al., 1992).
The Panel notes that homologous proteins of Sin a 1 and Bra n 1 are also potentially allergenic for
mustard-sensitive individuals.
Table 3: Chemical and physical data for behenic acid
Chemical and physical properties Unit Speciﬁc range Analytical methods
Acidic value mg KOH/g 162–168 ISO 660, 1996
Iodine value g/100 g Max. 2 ISO 3961, 1996
Nickel % Max. 0.1
Fatty acid distribution % Gas chromatography
ISO 5508, 1990/5509, 1978
≤ C18 Max. 5
C20 Max. 12
C22:0 behenic acid Min. 85
C22:1 erucic acid Max. 0.5
> C22 Max. 4
Boiling point °C > 270(a)
Melting point °C Approx. 75(b)
ISO: International Organization for Standardization.
(a): The boiling point of pure behenic acid is 306°C.
(b): The melting point of pure behenic acid is 80°C.
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3.5.1.4. Stability
No stability data has been provided by the applicant on the food allergen-derived preparation
(behenic acid).
3.5.2. Food allergen-derived foodstuffs (emulsiﬁers)
3.5.2.1. General speciﬁcations
The speciﬁcations for each emulsiﬁer identiﬁed by its E number (E 470a, E 471 and E 477) are
given in Regulation 231/2012 laying down the speciﬁcations for food additives listed in Annexes II and
III to Regulation (EC) No 1333/2008 of the European Parliament and of the Council.
3.5.2.2. Manufacturing process
The Panel notes that in foods, emulsiﬁers are widely used as additives in a variety of food products
to control and improve texture. Glycerol and oils or fats (triglycerides) are the raw materials used for
the production of mono- and diglycerides. The oils and fats employed in emulsiﬁer production are
widely used throughout the food industry, including but not limited to palm, sunﬂower, rapeseed and
soy. As an alternative to triglycerides, the corresponding fatty acids can also be used. Monoglycerides
can be further esteriﬁed with acids, i.e. tartaric acid, lactic acid, citric acid or acetic acid, to produce
other emulsiﬁers with a range of functional properties. According to the applicant, other emulsiﬁers for
food use that can be based on behenic acid are polyglycerol esters and propylene glycol esters.
The functional properties of emulsiﬁers can be controlled through the raw materials used. An
emulsiﬁer made from behenic acid can, according to the applicant, be used for example in food
products to control fat crystallisation, which is important in speciﬁc products where recipes have been
developed to avoid trans-fatty acids, such as vegetable spreads.
The applicant states that, depending on the type of emulsiﬁer manufactured, the ﬁnal content of
behenic acid in the emulsiﬁer is 25–85%. The applicant also states that the manufacturing process
conforms to the BRC Global Standard of Food Safety (Issue 6, July 2011) and the ISO 9001: 2008
Management standards.
3.5.2.3. Allergen speciﬁcations
No data was provided by the applicant on any emulsiﬁer.
3.5.2.4. Stability
Stability of the emulsiﬁers was not considered by the applicant.
3.6. Scientiﬁc data on allergenicity
3.6.1. Human intervention studies
No human intervention studies on the food allergen-derived preparation (behenic acid) or the food
allergen-derived foodstuff(s) (or the emulsiﬁers) have been provided.
3.6.2. Human observational studies
No human observational studies (e.g. case reports) of allergic reactions to the food allergen-derived
preparation (behenic acid) or the food allergen-derived foodstuff(s) (or the emulsiﬁers) have been
provided.
3.6.3. Animal studies
No animal studies with the food allergen-derived preparation (behenic acid) or the food allergen-
derived foodstuff(s) (the emulsiﬁers) have been provided.
3.6.4. In vitro studies on the food allergen-derived preparation (behenic acid)
3.6.4.1. ELISA assays
The applicant states that two samples of behenic acid of mustard origin were tested with an ELISA
assay for residual mustard allergens. The limit of detection (LOD) is reported to be 2.5 mg/kg. The
method for protein extraction from the oil is well described. However, the antibodies were raised
Behenic acid from mustard seed protein
www.efsa.europa.eu/efsajournal 11 EFSA Journal 2016;14(11):4631
against a generic mustard allergen which was not better speciﬁed, and therefore the Panel did not
consider the results of this test in the context of this application.
Three different batches of behenic acid were tested using an ELISA test for mustard seed protein with
a limit of quantiﬁcation (LOQ) of 1 mg/kg. The assay was developed using seed proteins from S. alba and
B. nigra. The assay has been shown to detect seed proteins from S. alba and B. nigra, but also from
B. juncea, by using positive standards with known amounts of seed proteins from these three species of
mustard. The Panel considers that, although the method for protein extraction from the oil is not
speciﬁed in the application (claimed as proprietary by the company manufacturing the ELISA test), the
information provided on the method of analysis is sufﬁcient to conclude that this assay is appropriate for
testing the presence of residual mustard allergens in behenic acid samples complying with the
speciﬁcations given in Section 3.5.1. Mustard allergens were not detected in any of the batches.
3.6.4.2. Passive sensitisation histamine release test (HR-test)
The biological activity of allergens can also be determined by their efﬁcacy to activate passively
sensitised stripped basophils by measuring release of histamine from the sensitised cells. The
Panel notes that the results are dependent on the serum used for passive sensitisation of the stripped
basophils. Thus, the serum should contain immunoglobulin E (IgE) in high concentrations against the
relevant allergens in the extract.
Among 37 sera screened for mustard reactivity, the applicant reports that three sera fulﬁlled the
criteria for sensitising capacity (releasing > 10 ng histamine/mL at a concentration of 1 ng mustard
standard extract/mL). Buffy coats used for passive sensitisation were collected at the Blood Bank
(National University Hospital of Copenhagen). Since the Blood Bank has a general ethical approval to
hand out buffy coats making sure that the blood donors are anonymous, the applicant refers that it
was not possible to characterise blood donors regarding their clinical history of mustard allergy.
The study plan included testing by passive sensitisation of stripped basophils using sera with high
reactivity against mustard and subsequent challenge of the passively sensitised basophils with a freshly
made extract from S. alba (L.) (yellow mustard) seeds. Results are expressed as the release of
histamine in ng/mL and the biological activity is expressed as the lowest concentration of test material
inducing > 10 ng histamine release/mL. The method is used routinely and validated by an accredited
laboratory according to EN ISO/IEC 17025: 2005, and has an in-house assay for measuring histamine
release from basophils obtained from blood bank buffy coat.
The test was applied to six different batches of behenic acid. The LOD was 30 pg dry mustard
seed/mg sample, which is equal to 0.03 mg/kg. Mustard allergens were not detected in any of the
batches. The applicant concluded that the behenic acid has less than 0.03 mg/kg mustard residue and
that the content of the actual mustard protein is even less, since the normal protein content of
mustard is about 26% (Remington, 2013).
The Panel notes that behenic acid is produced from B. juncea/B. nigra and not from S. alba seeds,
and that the major mustard allergen in B. juncea seeds is Bra j 1, whereas in S. alba seeds are Sin a
1, Sin a 2, Sin a 3 and Sin a 4. However, the Panel also notes that Bra j 1 and Sin a 1 have a similar
primary structure and share a homologous epitope (Gonzalez de la Pe~na et al., 1991; Monsalve et al.,
1993, 2001). Therefore, the Panel considers that, since the reference material used in this study was
not the most appropriate for testing the allergenicity of behenic acid in vitro, the results of the HR-test
provide only limited evidence that residual mustard in behenic acid may be < 0.03 mg/kg.
3.7. Exposure to the food allergen (mustard)
Considering that the highest amount of emulsiﬁers ingested per person on a single occasion is
1,400 mg for adults (Section 3.4), that behenic acid constitutes 25–85% of the ﬁnal emulsiﬁer, and
that the typical amount of an emulsiﬁer in a food item is maximum 1% on a weight basis, the
applicant calculated the maximum amount of mustard protein that could be consumed from emulsiﬁers
manufactured from behenic acid on a single occasion by an adult using the LOD of 0.03 mg/kg from
the passive sensitisation HR-test (Section 3.6.4). However, the Panel considers that using the LOQ of
1 mg/kg from the ELISA assay would be more appropriate, as follows:
ð1,400mg 85 1mg/kgÞ : ð100 1,000,000Þ ¼ 0:00119mg mustard proteins.
The Panel notes that the maximum amount of mustard protein that could be consumed from
emulsiﬁers manufactured from behenic acid on a single occasion by an adult under the proposed
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conditions of use would be around 0.00119 mg. The Panel also notes that protein doses triggering
allergic reactions in mustard-allergic individuals have been reported to be are around 1 mg (EFSA NDA
Panel, 2014).
4. Conclusions
The Panel considers that mustard allergens may not be carried over into behenic acid after the two
distillation steps reported in the manufacturing process in amounts beyond 1 mg/kg. No human or
animal data on the allergenicity of either behenic acid or the emulsiﬁers manufactured thereof in vivo
were provided by the applicant. The Panel notes, however, that the maximum amount of mustard
protein that could be consumed from emulsiﬁers manufactured from behenic acid (E 470a, E 471 and
E 477) on a single occasion by an adult under the proposed conditions of use would be around
0.00119 mg, which is about 1,000 times lower than the protein doses reported to trigger allergic
reactions in mustard-allergic individuals (around 1 mg).
On the basis of the data presented, the Panel concludes that oral consumption of emulsiﬁers
(E 470a, E 471 and E 477) manufactured using behenic acid from mustard seeds is unlikely to trigger
an allergic reaction in susceptible individuals (i.e. mustard-allergic individuals) under the proposed
conditions of use.
Documentation provided to EFSA
1) Notiﬁcation on behenic acid from mustard seed protein to be used in the manufacturing of
emulsiﬁers E 470a, E 471, E 472, E 475 and E 477 pursuant to Article 21(2) of Regulation
(EU) No 1169/2011 – for permanent exemption from labelling. August 2015. Submitted by
DuPont Nutrition Biosciences Aps.
2) Additional information submitted by the applicant upon EFSA’s request on 20 September
2016.
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